Newsy's Latest Health News

The FDA advises healthcare workers to adhere to the authorized two-dose regimen for COVID-19 vaccines, warning against premature changes to dosing schedules. This follows a suggestion to reduce doses to extend vaccine supplies, which the FDA says could risk public health without supporting data. Meanwhile, Moderna plans to increase its vaccine production, aiming to deliver up to 1 billion doses in 2021, with significant investments in manufacturing and staffing. The company has already supplied 18 million doses to the US government. Special thanks are given to Kaiser Health News for their collaboration.

What is the FDA's stance on altering the COVID-19 vaccine dosing schedule?

• They support reducing doses to speed up immunization.

• They recommend a single-dose regimen for faster results.

• They advise sticking to the authorized two-dose regimen.

• They have no specific guidance on dosing schedules.

What potential risk does the FDA associate with changing the vaccine dosing schedule without data?

• Increased vaccine efficacy

• Faster vaccine distribution

• Improved public health

• Risk to public health

What did a Trump administration science adviser suggest regarding vaccine doses?

• Using vaccines only for high-risk groups

• Increasing the number of doses per person

• Reducing doses to stretch supplies

• Eliminating the need for vaccines

How many doses does Moderna aim to produce by the end of the first quarter?

• 50 million doses

• 100 million doses

• 200 million doses

• 1 billion doses

What is Moderna's production target for the entire year?

• 1.5 billion doses

• 500 million doses

• 750 million doses

• 1 billion doses